GSDME and hepatocellular carcinoma: Conversely, when HCC cells were treated with 2-BP, GSDME protein expression further decreased in the CHX + 2-BP group compared to the CHX group (Figure 4g,i), indicating that inhibiting GSDME palmitoylation promoted its degradation.